Current stock page

Financial Data

ONC Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

ONCBeOne Medicines AG

Healthcare / Biotechnology

Leader

Sector Leader

Very BullishEdge 10/10
$416.54+$0.58 (+0.14%)

Latest quote

  • Momentum
    91
  • Value
    71
  • Quality
    78
  • Risk resilience
    72
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$1.89B$1.71B$1.51B$1.5B$1.41B$1.32B$1.12B$1.13B
Gross Profit$1.67B$1.53B$1.35B$1.36B$1.22B$1.15B$952.28M$967.26M
Operating Income$418.68M$325.05M$249.9M$185.04M$163.11M$87.89M$11.1M-$79.43M
Net Income$384.71M$237.01M$227.36M$66.5M$124.84M$94.32M$1.27M-$151.88M
EPS$3.38$27.04$26.65$7.67$14.69$0.87$0.01-$1.43
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow$508.71M$664.16M$201.94M$417.35M$402.55M$263.6M$44.08M$75.16M
Capital Expenditure-$35.18M-$68.27M-$40.91M-$286.07M-$48.08M-$63.83M-$116.41M-$92.48M
Free Cash Flow$473.53M$595.89M$161.03M$131.28M$354.47M$199.77M-$72.33M-$17.32M
Net Cash Provided By Operating Activities$508.71M$664.16M$201.94M$417.35M$402.55M$263.6M$44.08M$75.16M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$9.88B$9.18B$8.55B$8.19B$7.63B$6.3B$5.84B$5.92B
Total Debt$1.15B$1.14B$1.15B$2B$1.02B$1.03B$996.83M$1.08B
Cash And Cash Equivalents$5.78B$5.1B$4.79B$4.55B$4.04B$2.76B$2.52B$2.63B
Total Liabilities$4.06B$4B$3.79B$3.83B$3.5B$2.53B$2.34B$2.59B
Total Stockholders Equity$5.82B$5.17B$4.76B$4.36B$4.13B$3.77B$3.5B$3.33B
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio52.1457.8470.71—————
P/B ratio8.27.337.62—————
P/S ratio7.17———————
Debt To Equity0.20.220.240.460.250.270.280.32
Free Cash Flow Yield2.85%3.28%2.33%—————
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio52.1457.8470.71—————
P/B ratio8.27.337.62—————
P/S ratio7.17———————
Return On Equity15.73%12.67%10.78%6.58%1.66%-4.71%-11.21%-19.35%
Debt To Equity0.20.220.240.460.250.270.280.32

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe66.97x
Pb10.67x
Revenue Growth Yoy33.81%
EPS Growth Yoy-76.99%
Gross Margin88.39%
Operating Margin17.82%
ROE18.24%
ROIC12.08%
Debt To Equity0.2
FCF Yield3.27%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$416.54
Volume345,456
RSI (14)67.46
MACD14.24
MACD signal9.85
MACD histogram4.39
ADX (14)19.76
SMA (50)$369.18
SMA (200)$327.80
ATR (14)$12.44
Historical volatility (annualized)38.61%
Volume (20-day average)467,036

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score72/100
Beta0.68
Annual volatility34.16%
Max Drawdown-30.89%
Sharpe Ratio0.42
VaR (95%, 1-day)-3.00%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

ONC Financial Data FAQ

What is BeOne Medicines AG's revenue?

BeOne Medicines AG's revenue is one of the core financial data points for ONC. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is BeOne Medicines AG's revenue growing?

Revenue growth shows whether BeOne Medicines AG is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is ONC's EPS?

ONC's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is BeOne Medicines AG's net income?

BeOne Medicines AG's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does BeOne Medicines AG generate?

Free cash flow shows how much cash BeOne Medicines AG generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does BeOne Medicines AG have?

Cash and debt help frame ONC's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.